BRAF V600E mutation in a histiocytic sarcoma arising from hairy cell leukemia

Journal of Clinical Oncology

Volumn 32, Issue 35, 2014, Pages e117-e121

  Michonneau, David ^a,b   Kaltenbach, Sophie ^a,b   Derrieux, Coralie ^a,b   Trinquand, Amelie ^a,b   Brouzes, Chantal ^a,b   Gibault, Laure ^b,c   North, Marie Odile ^c   Delarue, Richard ^a,b   Varet, Bruno ^a,b   Emile, Jean Franҫois ^d   Brousse, Nicole ^a,b   Hermine, Olivier ^a,b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; CD45 ANTIGEN; CLADRIBINE; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; INTERFERON; PENTOSTATIN; PREDNISONE; RITUXIMAB; THALIDOMIDE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT; BRAF PROTEIN, HUMAN;

AGED; ARTICLE; ASTHENIA; BACKACHE; BLOOD CELL COUNT; BLOOD SAMPLING; CASE REPORT; CELL INFILTRATION; CELL TRANSDIFFERENTIATION; COMPARATIVE GENOMIC HYBRIDIZATION; COMPUTER ASSISTED TOMOGRAPHY; FEVER; FLOW CYTOMETRY; GENE MUTATION; GENE REARRANGEMENT; HAIRY CELL LEUKEMIA; HISTIOCYTIC SARCOMA; HUMAN; IMMUNOGLOBULIN GENE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LUNG LESION; LYMPH NODE BIOPSY; MALE; MEDICAL HISTORY; MONOCYTE; PYROSEQUENCING; SPLENECTOMY; TREATMENT RESPONSE; TUMOR CELL; CELL PROLIFERATION; COMPLICATION; GENETICS; LEUKEMIA, HAIRY CELL; MUTATION; RECURRENT DISEASE; REMISSION;

AGED; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CLADRIBINE; FLOW CYTOMETRY; HISTIOCYTIC SARCOMA; HUMANS; LEUKEMIA, HAIRY CELL; MALE; MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; RECURRENCE; REMISSION INDUCTION;

EID: 84918571169     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.49.0078     Document Type: Article

References (21)

1. Tiacci E, Trifonov V, Schiavoni G, et al: BRAF mutations in hairy-cell leukemia. N Engl J Med 364:2305-2315, 2011
2. Dietrich S, Glimm H, Andrulis M, et al: BRAF inhibition in refractory hairy-cell leukemia. N Engl J Med 366:2038-2040, 2012
3. Moreau S, Saiag P, Aegerter P, et al: Prognostic value of BRAF(V600) mutations in melanoma patients after resection of metastatic lymph nodes. Ann Surg Oncol 19:4314-4321, 2012
4. Haroche J, Charlotte F, Arnaud L, et al: High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood 120:2700-2703, 2012
5. Haroche J, Cohen-Aubart F, Emile J-F, et al: Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation. Blood 121: 1495-1500, 2013
6. Hornick JL, Jaffe ES, Fletcher CD: Extranodal histiocytic sarcoma: Clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol 28:1133-1144, 2004
7. Shao H, Xi L, Raffeld M, et al: Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: A study of seven cases. Mod Pathol 24:1421-1432, 2011
8. Hure MC, Elco CP, Ward D, et al: Histiocytic sarcoma arising from clonally related mantle cell lymphoma. J Clin Oncol 30:e49-e53, 2012
9. Kumar R, Khan SP, Joshi DD, et al: Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A. Pediatr Blood Cancer 56:307-310, 2011
10. Wang E, Papalas J, Hutchinson CB, et al: Sequential development of histiocytic sarcoma and diffuse large B-cell lymphoma in a patient with a remote history of follicular lymphoma with genotypic evidence of a clonal relationship: A divergent (bilineal) neoplastic transformation of an indolent B-cell lymphoma in a single individual. Am J Surg Pathol 35:457-463, 2011
11. Wang E, Hutchinson CB, Huang Q, et al: Histiocytic sarcoma arising in indolent small B-cell lymphoma: Report of two cases with molecular/genetic evidence suggestive of a "transdifferentiation" during the clonal evolution. Leuk Lymphoma 51:802-812, 2010
12. Zeng W, Meck J, Cheson BD, et al: Histiocytic sarcoma transdifferentiated from follicular lymphoma presenting as a cutaneous tumor. J Cutan Pathol 38:999-1003, 2011
13. Hayase E, Kurosawa M, Yonezumi M, et al: Aggressive sporadic histiocytic sarcoma with immunoglobulin heavy chain gene rearrangement and t(14;18). Int J Hematol 92:659-663, 2010
14. Chen W, Lau SK, Fong D, et al: High frequency of clonal immunoglobulin receptor gene rearrangements in sporadic histiocytic/dendritic cell sarcomas. Am J Surg Pathol 33:863-873, 2009
15. Alonso-Dominguez JM, Calbacho M, Talavera M, et al: Cytogenetics findings in a histiocytic sarcoma case. Case Rep Hematol 2012:428279, 2012
16. de Pooter RF, Kee BL: E proteins and the regulation of early lymphocyte development. Immunol Rev 238:93-109, 2010
17. Ramírez J, Lukin K, Hagman J: From hematopoietic progenitors to B cells: Mechanisms of lineage restriction and commitment. Curr Opin Immunol 22:177-184, 2010
18. Abu-Sanad A, Warsi A, Michel RP, et al: Long-term remission after autologous stem-cell transplantation for relapsed histiocytic sarcoma. Curr Oncol 19:e289-e291, 2012
19. Bailey KM, Castle VP, Hummel JM, et al: Thalidomide therapy for aggressive histiocytic lesions in the pediatric population. J Pediatr Hematol Oncol 34:480-483, 2012
20. Shukla N, Kobos R, Renaud T, et al: Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab. Cancer 118:3719-3724, 2012
21. Schlick K, Aigelsreiter A, Pichler M, et al: Histiocytic sarcoma: Targeted therapy-Novel therapeutic options? A series of 4 cases. Onkologie 35:447-450, 2012